Relief Therapeutics Holding SA (ETR:RLF) | WebDisclosure

Switch to English

9821	Sociétés
197104	Mots-clés
128177	Articles
104825	Communiqués

Accueil
Sociétés
Relief Therapeutics Holding SA

COMMUNIQUÉ DE PRESSE

publié le 08/10/2025 à 07:00, il y a 4 mois 1 jour

Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreement for Business Combination
Relief Therapeutics and NeuroX sign definitive agreement for business combination to create MindMaze Therapeutics Holding SA. Transaction poised to advance evidence-based neurotherapeutic solutions and precision medicine

Business Combination Precision Medicine Relief Therapeutics MindMaze NeuroX
BRÈVE

publiée le 14/08/2025 à 07:05, il y a 5 mois 26 jours

Relief Therapeutics publie son rapport semestriel 2025

THÉRAPEUTIQUE DE SECOURS RLF-TD011 RLF-OD032 Rapport Semestriel 2025 Partenariat NeuroX
BRÈVE

publiée le 14/08/2025 à 07:05, il y a 5 mois 26 jours

Relief Therapeutics Releases 2025 Half-Year Report

Relief Therapeutics RLF-TD011 RLF-OD032 2025 Half-Year Report NeuroX Partnership
COMMUNIQUÉ DE PRESSE

publié le 14/08/2025 à 07:00, il y a 5 mois 26 jours

Relief Therapeutics Publishes 2025 Half-Year Report
Relief Therapeutics published its 2025 half-year report, highlighting progress in pipeline candidates for rare diseases and financial status. Corporate update includes advances in wound care and liquid formulation for phenylketonuria

Financial Status Relief Therapeutics Rare Diseases 2025 Half-Year Report Pipeline Candidates
BRÈVE

publiée le 11/08/2025 à 07:05, il y a 5 mois 29 jours

Publication du rapport semestriel 2025 de Relief Therapeutics

THÉRAPEUTIQUE DE SECOURS Traitements Innovants Genève Société Biopharmaceutique Rapport Semestriel 2025
BRÈVE

publiée le 11/08/2025 à 07:05, il y a 5 mois 29 jours

Relief Therapeutics Advances 2025 Half-Year Report Publication

Biopharmaceutical Company Relief Therapeutics Innovative Treatments Geneva Half-Year Report 2025
COMMUNIQUÉ DE PRESSE

publié le 11/08/2025 à 07:00, il y a 5 mois 29 jours

Relief Therapeutics Advances Publication of 2025 Half-Year Report
Relief Therapeutics advances publication of its 2025 half-year report from August 27 to August 14, 2025, indicating completion ahead of schedule. Company to provide shareholder update and financial statements

Biopharmaceutical Relief Therapeutics Publication Innovative Treatment Options 2025 Half-Year Report
BRÈVE

publiée le 29/07/2025 à 07:05, il y a 6 mois 11 jours

Relief Therapeutics and NeuroX to Merge, Expanding AI Health Tech

SIX Swiss Exchange Mergers & Acquisitions Neurological Diseases AI Health Tech MindMaze
BRÈVE

publiée le 29/07/2025 à 07:05, il y a 6 mois 11 jours

Relief Therapeutics et NeuroX fusionnent, développant ainsi leur technologie de santé basée sur l'IA

SIX Swiss Exchange Fusions Et Acquisitions Maladies Neurologiques MindMaze Technologie De La Santé Basée Sur L'IA
COMMUNIQUÉ DE PRESSE

publié le 29/07/2025 à 07:00, il y a 6 mois 11 jours

Relief Therapeutics Announces Proposed Business Combination with NeuroX, successor to MindMaze
Relief Therapeutics to merge with NeuroX, successor to MindMaze, creating a SIX-listed, AI-driven health tech company. Transaction expected to close in Q4 2025

Business Combination Relief Therapeutics MindMaze NeuroX AI-driven Health Tech

Les Echos

Publié le 06/02/2026 à 18:22, il y a 2 jours 13 heures

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Publié le 06/02/2026 à 18:22, il y a 2 jours 13 heures

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Publié le 06/02/2026 à 16:01, il y a 2 jours 15 heures

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Publié le 06/02/2026 à 16:01, il y a 2 jours 15 heures

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Publié le 06/02/2026 à 07:54, il y a 2 jours 23 heures

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 08/02/2026 à 21:00, il y a 10 heures 22 minutes

Banyan Gold Extends Airstrip and High-Grade Mineralization to 350m Vertical Depth, Yukon, Canada
Publié le 07/02/2026 à 01:00, il y a 2 jours 6 heures

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Publié le 06/02/2026 à 23:10, il y a 2 jours 8 heures

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Publié le 06/02/2026 à 22:01, il y a 2 jours 9 heures

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Publié le 06/02/2026 à 15:30, il y a 2 jours 15 heures

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland

Voir tout ACCESSWIRE

EQS Group

Publié le 09/02/2026 à 07:00, il y a 22 minutes

SoftwareOne delivers 1.4% FY 2025 constant currency growth on a combined like-for-like basis / Announces nomination of Barend Fruithof as additional Board member
Publié le 09/02/2026 à 07:00, il y a 22 minutes

Branicks Group AG: Further leasing success at the Pressehaus building on Berlin’s Alexanderplatz
Publié le 07/02/2026 à 21:00, il y a 1 jour 10 heures

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Publié le 07/02/2026 à 16:35, il y a 1 jour 14 heures

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Publié le 07/02/2026 à 16:20, il y a 1 jour 15 heures

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU